[EN] SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS<br/>[FR] COMPOSÉS DE PYRIDOPYRIMIDINONYL SUBSTITUÉS UTILES EN TANT QU'ACTIVATEURS DE LYMPHOCYTES T
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2021041588A1
公开(公告)日:2021-03-04
Disclosed are compounds of Formula (I):(I) or a salt thereof, wherein: R1, R2, R4, R5, and m are defined herein. Also disclosed are methods of using such compounds to inhibit the activity of one or both of diacylglycerol kinase alpha (DGK ) and diacylglycerol kinase zeta (DGK ), and pharmaceutical compositions comprising such compounds. These compounds are useful in the treatment of viral infections and proliferative disorders, such as cancer.